Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

vimseltinib dihydrate

(vim-SEL-tih-nib dy-HY-drayt)
A drug used to treat adults with tenosynovial giant cell tumor, a rare, usually benign (not cancer) tumor that affects the joints. It is used when surgery may make the symptoms worse or cause severe problems. It is also being studied in the treatment of other conditions related to cancer. Vimseltinib dihydrate blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called Romvimza.
Search NCI's Dictionary of Cancer Terms